Important Notice for Neogen Corporation Investors
Shareholders who have experienced losses exceeding $100,000 are highly encouraged to reach out for assistance regarding their situation.
Deadline Approaching
The Law Offices of Howard G. Smith is reminding investors about the crucial deadline to submit a lead plaintiff motion related to a class action lawsuit. This lawsuit pertains to investors who acquired Neogen Corporation's common stock, identified by the ticker NEOG, within a specified timeframe. The deadline to file is approaching fast. Those impacted should take action promptly.
Understanding the Situation
Neogen recently indicated that its financial performance has suffered significantly. A substantial non-cash goodwill impairment charge of $461 million was revealed, attributed to its acquisition of 3M Company. Additionally, the company's outlook for revenue and earnings before interest, taxes, depreciation, and amortization (EBITDA) has been revised downwards due to unexpected operational challenges.
Effects of Recent Financial Disclosures
Upon releasing these developments, Neogen's stock price witnessed a notable decline. On the date of the announced impairment, the stock fell by $0.71, reflecting a drop of 5.4%, ultimately closing at $12.36 per share. As if this was not enough, further disappointment came when Neogen disclosed continued revenue drops along with leadership changes, which pushed the stock down another 28.7% to $5.02.
Ongoing Challenges
Well into the year, continued disappointing news has kept a dampening effect on Neogen’s stock. Announcements concerning decreased EBITDA margins and inventory write-offs further impacted the company’s market confidence, leading to another decline to $4.96 per share. Such developments have understandably raised concerns among investors regarding the viability and profitability of their holdings.
The Lawsuit’s Allegations
The class action lawsuit filed against Neogen alleges that throughout the designated class period, misleading statements were made by company executives. It claims not only did the company fail to disclose evident operational issues, but it also misled investors regarding their financial health. For those who purchased Neogen stocks during this tumultuous time, it is crucial to understand your potential claims and rights.
Take Action Now
If you or someone you know bought shares in Neogen Corporation within the specified class period and experienced losses, reach out to consult about legal options. Prompt action may provide a path toward recovery of losses experienced due to these adverse developments.
Contact Information for Support
The Law Offices of Howard G. Smith are available to assist anyone interested in participating in the lawsuit. Interested parties can contact the firm by email at howardsmith@howardsmithlaw.com or by phone at (215) 638-4847. Potential participants are encouraged to seek guidance on their legal options as soon as possible.
Frequently Asked Questions
What is the current stock price of Neogen Corporation (NEOG)?
As of the latest data, Neogen Corporation (NEOG) is trading at approximately $4.84.
What does the lawsuit against Neogen Corporation entail?
The lawsuit alleges misleading statements from executives which affected stock prices adversely, prompting investors to seek recovery.
How can I participate in the class action lawsuit?
Investors should contact the Law Offices of Howard G. Smith for details on how to join and file the necessary paperwork.
Who should contact the law offices?
Anyone who purchased Neogen Corporation stocks during the affected class period and who has suffered a significant financial loss should reach out for legal support.
What are the risks of not participating in the lawsuit?
Investors who choose not to participate may miss the opportunity for recovery associated with their losses if the court rules in favor of the class action.
